Rezazadeh Saman, Chew Derek S, Miller Robert J H, Klassen Sheila, Pournazari Payam, Bennett Graham, Lang Eddy, Quinn F Russell
*Libin Cardiovascular Institute of Alberta,Department of Cardiac Sciences,University of Calgary,Calgary,AB.
†Departments of Medicine,University of Calgary,Calgary,AB.
CJEM. 2018 Nov;20(6):841-849. doi: 10.1017/cem.2018.415. Epub 2018 Oct 8.
Oral anticoagulation (OAC) reduces stroke risk in patients with atrial fibrillation (AF) or atrial flutter (AFL). However, OAC initiation rates in patients discharged directly from the emergency department (ED) are low. We aimed to address this care gap by implementing a quality improvement intervention.
The study was performed in four Canadian urban EDs between 2015 and 2016. Patients were included if they had an electrocardiogram (ECG) documenting AF/AFL in the ED, were directly discharged from the ED, and were alive after 90 days. Baseline rates of OAC initiation were determined prior to the intervention. Between June and December 2016, we implemented our intervention in two EDs (ED-intervention), with the remaining sites acting as controls (ED-control). The intervention included a reminder statement prompting OAC initiation according to guideline recommendations, manually added to ECGs with a preliminary interpretation of AF/AFL, along with a decision-support algorithm that included a referral sheet. The primary outcome was the rate of OAC initiation within 90 days of the ED visit.
Prior to the intervention, 37.2% OAC-naïve patients with ECG-documented AF/AFL were initiated on OAC. Following implementation of the intervention, the rate of OAC initiation increased from 38.6% to 47.5% (absolute increase of 8.5%; 95% CI, 0.3% to 16.7%, p=0.04) among the ED-intervention sites, whereas the rate remained unchanged in ED-control sites (35.3% to 35.9%, p=0.9).
Implementation of a quality improvement intervention consisting of a reminder and decision-support tool increased initiation of OAC in high-risk patients. This support package can be readily implemented in other jurisdictions to improve OAC rates for AF/AFL.
口服抗凝药(OAC)可降低心房颤动(AF)或心房扑动(AFL)患者的中风风险。然而,直接从急诊科(ED)出院的患者中OAC起始率较低。我们旨在通过实施一项质量改进干预措施来解决这一护理差距。
该研究于2015年至2016年在加拿大四个城市的急诊科进行。纳入标准为在急诊科有心电图(ECG)记录AF/AFL、直接从急诊科出院且90天后仍存活的患者。在干预前确定OAC起始的基线率。2016年6月至12月期间,我们在两个急诊科实施了干预措施(ED-干预组),其余科室作为对照组(ED-对照组)。干预措施包括根据指南建议提示OAC起始的提醒语句,手动添加到初步解读为AF/AFL的心电图上,以及包含转诊单的决策支持算法。主要结局是急诊就诊后90天内OAC起始率。
干预前,37.2%心电图记录为AF/AFL的未使用OAC患者开始使用OAC。实施干预后,ED-干预组中OAC起始率从38.6%增至47.5%(绝对增加8.5%;95%CI,0.3%至16.7%,p = 0.04),而ED-对照组的起始率保持不变(35.3%至35.9%,p = 0.9)。
实施由提醒和决策支持工具组成的质量改进干预措施可提高高危患者OAC的起始率。该支持方案可在其他地区轻松实施,以提高AF/AFL患者的OAC使用率。